Newsroom
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Read moreImmunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Read more
Video review of the first results of the yellow fever study
First results of yellow fever study published in the Lancet
Read more
Yellow fever study : expansion of patient categories
Read more
MSF Foundation Supports Epicentre in New Yellow Fever Study
Read moreHeadline
The MSF Foundation supports the development of rapid diagnostic tests for measles and meningitis
A new partner for the 3D program: the EQWAL Foundation
MSF Foundation in Video
3D program is deployed in Syria
Women's Health and Physiotherapy: Fighting Cancer in Malawi
Officially launching of Antibiogo : Webinar
News
Publications
Antibiogo : Results published in Nature Communications
Read more
Press Review
Antibiogo : The project is presented in The Good AI magazine
Read more
No news for now.